miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells

International Journal of Molecular Medicine

Volumn 30, Issue 5, 2012, Pages 1013-1020

  Zhao, Haien ^a   Guo, Mingjun ^a   Zhao, Guangyi ^a   Ma, Qiong ^a   Ma, Baoan ^a   Qiu, Xiuchun ^a   Fan, Qingyu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ezrin protein; Invasion; Migration; miR 183; Osteosarcoma

Indexed keywords

EZRIN; MICRORNA; MICRORNA 183; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; METASTASIS INHIBITION; METASTASIS POTENTIAL; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DOWN-REGULATION; GENE EXPRESSION; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; RNA INTERFERENCE;

EID: 84866616313     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1111     Document Type: Article

References (40)

1. Bentzen SM, Poulsen HS, Kaae S, Jensen OM, Johansen H, Mouridsen HT, et al: Prognostic factors in osteosarcomas. A regression analysis. Cancer 62: 194-202, 1988.
2. Davis AM, Bell RS and Goodwin PJ: Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12: 423-431, 1994.
3. Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC and Gebhardt MC: Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 429: 286-291, 2004.
4. Ambros V and Lee RC: Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 265: 131-158, 2004.
5. Pillai RS, Bhattacharyya SN and Filipowicz W: Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118-126, 2007.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004.
7. Caldas C and Brenton JD: Sizing up miRNAs as cancer genes. Nat Med 11: 712-714, 2005.
8. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
9. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, et al: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is downregulated in glioblastoma. Cancer Res 68: 3566-3572, 2008.
10. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L and Zucman-Rossi J: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963, 2008.
11. Motoyama K, Inoue H, Takatsuno Y, et al: Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075, 2009.
12. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, et al: Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 6: 1830-1840, 2008.
13. Mattie MD, Benz CC, Bowers J, Sensinger K, et al: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24, 2006.
14. Wang G, Mao W and Zheng S: MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582: 3663-3668, 2008.
15. Chen X, Yang TT, Wang W, Sun HH, et al: Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology 61: 37-44, 2009.
16. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, et al: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
17. Lowery AJ, Miller N, Dwyer RM and Kerin MJ: Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 10: 502, 2010.
18. Doench JG and Sharp PA: Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511, 2004.
19. Tavazoie SF, Alarcon C, Oskarsson T, et al: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152, 2008.
20. Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sañudo A, Antunes AA and Srouqi M: Change in expression of miR-let7c, miR-100 and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 29: 265-269, 2011.
21. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA, miR-125a or miR-125b. J Biol Chem 282: 1479-1486, 2007.
22. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007.
23. Mazar J, DeBlasio D, Govindarajan SS, Zhang S and Perera RJ: Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. FEBS Lett 585: 2467-2476, 2011.
24. Wu L, Cai C, Wang X, Liu M, Li X and Tang H: MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett 585: 1322-1330, 2011.
25. Tan S, Li R, Ding K, Lobie PE and Zhu T: miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett 585: 2229-2234, 2011.
26. Li G, Luna C, Qiu J, Epstein DL and Gonzalez P: Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem 285: 5461-5471, 2010.
27. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005.
28. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS and Merlinom G: Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six21 as key metastatic regulators. Nat Med 10: 175-181, 2004.
29. Mangeat P, Roy C and Martin M: ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol 9: 187-192, 1999.
30. Bretscher A, Edwards K and Fehon RG: ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599, 2002.
31. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, Cheng DQ, Weng WH, Wu XS, Fei XZ, et al: Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 281: 71-81, 2009.
32. Hunter KW: Ezrin, a key component in tumor metastasis. Trends Mol Med 10: 201-204, 2004.
33. Weng WH, Ahlen J, Astrom K, Lui WO and Larsson C: Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11: 6198-6204, 2005.
34. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The membrane cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186, 2004.
35. Kim MS, Song, WS, Cho WH, Lee SY and Jeon DG: Ezrin expression predicts survival in stage IIB osteosarcomas. Clin Orthop Relat Res 459: 229-236, 2007.
36. Xu-Dong S, Zan S, Shui-Er Z, Li-Na T, Wen-Xi Y, Feng L and Yang Y: Expression of ezrin correlates with lung metastasis in Chinese patients with osteosarcoma. Clin Invest Med 32: E180-E188, 2009.
37. Wang YF, Shen JN, Xie XB Wang J and Huang G: Expression change of ezrin as a prognostic factor in primary osteosarcoma. Med Oncol 28: S636-S643, 2011.
38. Kang HW, Wang F, Wei Q Zhao YF, Liu M, Li X and Tang H: miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett 586: 897-904, 2012.
39. Wu L, Li H, Jia CY, Cheng W, et al: MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 586: 1038-1043, 2012.
40. Huang N, Lin J, Ruan J, Su N, et al: MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett 586: 884-891, 2012.